FRR Shares (Makes you Realise)

Equity

Home/ Are You A Trader/ Market Info/ Company Profile/ Smart Quotes

COMPANY PROFILE

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla

BSE1531.1043.85 (+2.95 %)

PREV CLOSE (Rs.) 1487.25

OPEN PRICE (Rs.) 1487.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 262723

TODAY'S LOW / HIGH (Rs.)1470.00 1553.00

52 WK LOW / HIGH (Rs.)1310.05 1702

NSE1532.5044.6 (+3 %)

PREV CLOSE( Rs. ) 1487.90

OPEN PRICE (Rs.) 1485.00

BID PRICE (QTY) 1532.50 (2947)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 5226395

TODAY'S LOW / HIGH(Rs.) 1469.00 1553.70

52 WK LOW / HIGH (Rs.)1335 1702.05

More From Company Profile

Smart Quotes

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Trade Value (Rs. in Lacs)

3998.40

Dividend Yield(%)

1.05

TTM EPS (Rs.)

66.91

P/E Ratio

22.88

Book Value (Rs.)

412.88

Face Value (Rs.)

MCap (Rs. in Mn)

1236747.89

Price/Earning (TTM)

20.66

Price/Sales (TTM)

7.34

Price/Book (MRQ)

3.71

PAT Margin (%)

25.85

ROCE (%)

21.59

Incorporation Year : 17-08 1935

Management Info :

Y K Hamied - Chairman Umang Vohra - Managing Director

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel,
Mumbai,
Maharashtra-400013

Phone : 022-24826000

Email : contactus@cipla.com

Website : www.cipla.com

Registrars Details :

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE, Luxembourg

NEWS

25Jul Cipla reports 10% rise in Q1 consolida
Cipla has reported result for first quarter ended June 30, 2025 (Q1FY26)..

22Jul Cipla signs definitive agreements for
Cipla has signed definitive agreements for investment in Optionally Conv..

31May USFDA concludes cGMP inspection at Cip
United States Food and Drugs Administration (USFDA) has concluded curren..

Financials

	QTR Jun 25	ANNUAL 25
Net Profit	13031.3	51576.5
Gross Profit	17439.5	64688.2
Operating Profit	18955.2	67631.6
Net Sales	50461.7	190448.5

Rs. in Millions

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Torrent Pharma (BSE)

3602.50 (2.46%)

M.Cap (Rs. in Cr)121924.97

Pfizer (BSE)

5354.75 (1.23%)

M.Cap (Rs. in Cr)24496.77

Solara Active Pharma (BSE)

695.80 (5.85%)

M.Cap (Rs. in Cr)3350.49

Alkem Laboratories (BSE)

5018.45 (0.41%)

M.Cap (Rs. in Cr)60003.10

Shareholding Pattern

	PROMOTERS	29.19%
	MUTUAL FUNDS/UTI	20.44%
	NON-INSTITUTION	16.31%
	FI/BANKS/INSURANCE	6.91%
	GOVERNMENT	0%
	FII	0%

Mf Holding

Scheme Name

Hold(%)

ICICI Pru Nifty Pha...

10.71

Nippon India Nifty ...

10.70

DSP Healthcare Fund...

8.82

Axis NIFTY Healthcare ETF

8.78

Aditya Birla SL Nif...

8.78

DSP Nifty Healthcare ETF

8.77

ICICI Pru Nifty Hea...

8.77

Attention Investors

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. Check your securities / MF / bonds in the consolidated account statement issued by NSDL/CDSL every month, Issued in the interest of Investors.

Risk Disclosure on Derivatives | Smart ODR | Mandatory Display | KYC Validation Links

BSE / NSE SEBI Registration No. INZ000279232, Depository Participant SEBI Registration No. – IN DP CDSL 132-2015

Mutual funds - ARN No. 81648 , Investment Adviser SEBI Registration No. : INA000008668.

CLOSE X

Risk Disclosures On Derivatives

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22

CIPLA LTD.

Smart Quotes

Attention Investors

Download Client Registration Documents

Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do's & Don't's) in Vernacular Language :

Filing complaints on SCORESEasy & quick

Risk Disclosures On Derivatives